Skip to main content

Diabetes, Type 2 News (Page 12)

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Tirzepatide Bests Semaglutide for Patients With Type 2 Diabetes

THURSDAY, Oct. 5, 2023 – Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European...

Study Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic

THURSDAY, Oct. 5, 2023 – While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal...

Durable Reductions in HbA1c, Body Weight Seen With Semaglutide

WEDNESDAY, Oct. 4, 2023 – Use of once-weekly subcutaneous semaglutide is associated with sustained reductions in hemoglobin A1c (HbA1c) and body weight, according to a study presented at the annual...

mHealth-Delivered Coaching Cuts Blood Glucose Levels in Patients With Diabetes

TUESDAY, Oct. 3, 2023 – A clinical pharmacist and health coach-delivered mobile health intervention can improve blood glucose levels in African American and Latinx populations, according to a study...

Tea Drinkers May Gain Better Blood Sugar Control

TUESDAY, Oct. 3, 2023 – Drinking dark tea daily may help balance blood sugar levels and stave off type 2 diabetes, the form of the disease most closely tied to obesity. This is the main message from...

Diabetes Could Speed Progression of Blood Cancer Myeloma

MONDAY, Oct. 2, 2023 – Diabetes may accelerate the growth of a blood cancer known as multiple myeloma, affecting overall survival, according to a new study. The research, published Sept. 29 in the...

Tight Glucose Control Does Not Affect Length of Time Needed in ICU

THURSDAY, Sept. 28, 2023 – For critically ill patients in the intensive care unit (ICU), tight glucose control does not affect the length of time that ICU care is needed, according to a study...

Racial, Ethnic Differences Seen for Benefits of Antihyperglycemic Agents

THURSDAY, Sept. 28, 2023 – There are racial/ethnic differences in the cardiorenal effects of sodium-glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists...

Pharmacist-Led Intervention Lowers HbA1c in Type 2 Diabetes

THURSDAY, Sept. 28, 2023 – A pharmacist-led intervention (UCMyRx) can result in a significant reduction in hemoglobin A1c (HbA1c) concentration among Hispanic patients with type 2 diabetes (T2D),...

FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines

WEDNESDAY, Sept. 27, 2023 – Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food...

Increase in Types 1 and 2 Diabetes Seen in U.S. Youth During Pandemic

TUESDAY, Sept. 26, 2023 – The incidence of type 1 and type 2 diabetes increased among U.S. youth during the COVID-19 pandemic, according to a study published online Sept. 21 in JAMA Network Open....

Morning, Afternoon Exercise May Cut Diabetes Risk

TUESDAY, Sept. 26, 2023 – Morning and afternoon physical activity are associated with a lower risk for developing type 2 diabetes, according to a study published online Sept. 20 in Diabetologia....

Once-Weekly Insulin Icodec Superior for HbA1c in Type 2 Diabetes

TUESDAY, Sept. 26, 2023 – For insulin-naive adults with type 2 diabetes, once-weekly insulin icodec (icodec) titrated with a dosing guide app (icodec with app) is superior for change in glycated...

Your Wrist Could Give Clues to Future Health

MONDAY, Sept. 25, 2023 – One day, it may be possible to monitor people for risk of disease through continuously measuring skin temperature. Researchers have found in a new study that wrist...

Breast Cancer Drug Piqray Could Trigger Dangerous High Blood Sugar

MONDAY, Sept. 25, 2023 – For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetes Mellitus

Related drug support groups

metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Lantus Solostar, Humalog, Farxiga, Novolog, Jardiance, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, liraglutide, Invokana, Glucophage, Humulin N, insulin degludec